Association of a failed noninvasive prenatal screening with the risk of cytogenetic abnormalities in a general‐risk population: A retrospective cohort study
Authors:
- 24 July 2026
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
Abstract
Objective: To investigate whether noninvasive prenatal screening (NIPS) failure in a general‐risk population is associated with an increased likelihood of cytogenetic abnormalities. Methods: This was a retrospective observational cohort study at a tertiary center, based on a general‐risk population. Singleton pregnancies that underwent NIPS between May 12, 2017, and July 30, 2021, at the Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China, were included. The outcomes were the incidence of common autosomal aneuploidies (trisomy 21, 18, or 13), sex chromosome aneuploidies (SCAs), and copy number variations (CNVs) on the first attempt. From the reports of NIPS, the pregnancies with a failure were compared with those with a success. Propensity score overlap weighting was applied to adjust for maternal age, paternal age, parity, body mass index, method of conception and gestational age at the first blood collection. Results: Of the 42 121 pregnancies included, 41 776 (99.18%) received reports and 345 (0.82%) did not on the first attempt at NIPS. Pregnancies with NIPS failure showed no significantly statistical difference in the risk for trisomy 21, 18, or 13 (0.29% vs. 0.23%; overlap weighting risk ratio [OW RR] 1.17; 95% CI 0.16–8.46), SCAs (4.08% vs. 7.89%; OW RR 0.53; 95% CI, 0.13–2.26) and CNVs (6.12% vs. 8.13%; OW RR 0.76; 95% CI, 0.23–2.53), compared with those with successful NIPS. These findings remained consistent in the sensitivity analyses. Conclusions: The evidence was insufficient that NIPS failure after first‐trimester ultrasound screening could be associated with an increased risk of common autosomal aneuploidies, SCAs, and CNVs. Our findings suggest that in a general‐risk population those who experience NIPS failure need to be managed on the basis of their basic risk.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (22ZR1409000)
- Science and Technology Commission of Shanghai Municipality (21Y11908000)
- National Key Research and Development Program of China (2021YFC2701600)
- National Key Research and Development Program of China (2021YFC2701601)
- Science, Technology and Innovation Commission of Shenzhen Municipality (LCYSSQ20220823091401002)
This publication has 25 references indexed in Scilit:
- Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic OutcomesJAMA Network Open, 2024
- The value of detailed first-trimester ultrasound in the era of noninvasive prenatal testingAmerican Journal of Obstetrics and Gynecology, 2023
- Position statement from the International Society for Prenatal Diagnosis on the use of non‐invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnanciesPrenatal Diagnosis, 2023
- Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening resultsAmerican Journal of Obstetrics and Gynecology, 2023
- Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnanciesAmerican Journal of Obstetrics and Gynecology, 2023
- Not all low fetal fraction cell‐free DNA screening failures are at increased risk for aneuploidyPrenatal Diagnosis, 2021
- Overlap WeightingJAMA, 2020
- Chromosomal abnormalities in products of conception of first-trimester miscarriages detected by conventional cytogenetic analysis: a review of 1000 casesJournal of Assisted Reproduction and Genetics, 2017
- Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United StatesAmerican Journal of Medical Genetics Part A, 2015
- Circulating cell free DNA testing: are some test failures informative?Prenatal Diagnosis, 2014